Related references
Note: Only part of the references are listed.Clinical and laboratory features of African-Brazilian patients with systemic sclerosis
Cristiane Mendes et al.
CLINICAL RHEUMATOLOGY (2020)
Association of radiographic findings in hand X-ray with clinical features and autoantibodies in patients with systemic sclerosis
Komei Sakata et al.
CLINICAL RHEUMATOLOGY (2020)
Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile
Christian Johana Banos-Hernandez et al.
CLINICAL RHEUMATOLOGY (2019)
A Machine Learning Classifier for Assigning Individual Patients With Systemic Sclerosis to Intrinsic Molecular Subsets
Jennifer M. Franks et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
Vincent Sobanski et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Senescence signature in skin biopsies from systemic sclerosis patients treated with senolytic therapy: potential predictor of clinical response?
Viktor Martyanov et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
Jessica K. Gordon et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Mycophenolate Mofetil Treatment of Systemic Sclerosis Reduces Myeloid Cell Numbers and Attenuates the Inflammatory Gene Signature in Skin
Monique Hinchcliff et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
Giuseppina Stifano et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?
Patricia Corzo et al.
CLINICAL RHEUMATOLOGY (2018)
Anti-nuclear autoantibodies in systemic sclerosis : News and perspectives
Yasuhito Hamaguchi et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2018)
Patients with systemic sclerosis-associated pulmonary arterial hypertension express a genomic signature distinct from patients with interstitial lung disease
Matthew Moll et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2018)
What is precision medicine?
Inke R. Koenig et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
A Functional Genomic Meta-Analysis of Clinical Trials in Systemic Sclerosis: Toward Precision Medicine and Combination Therapy
Jaclyn N. Taroni et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions
Silvia Bellando-Randone et al.
CURRENT RHEUMATOLOGY REPORTS (2017)
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
Viktor Martyanov et al.
PLOS ONE (2017)
Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities
John Varga et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Molecular stratification and precision medicine in systemic sclerosis from genomic and proteomic data
Viktor Martyanov et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
Controversies: molecular vs. clinical systemic sclerosis classification
Sindhu R. Johnson et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2016)
Subsets in systemic sclerosis: one size does not fit all
Valerie Leclair et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2016)
Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
Jaclyn N. Taroni et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
Eliza F. Chakravarty et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
Jessica K. Gordon et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Correction: Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms
PLoS Computational Biology (2015)
Experimentally-Derived Fibroblast Gene Signatures Identify Molecular Pathways Associated with Distinct Subsets of Systemic Sclerosis Patients in Three Independent Cohorts
Michael E. Johnson et al.
PLOS ONE (2015)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study
Stylianos T. Panopoulos et al.
LUNG (2013)
Intrinsic Gene Expression Subsets of Diffuse Cutaneous Systemic Sclerosis Are Stable in Serial Skin Biopsies
Sarah A. Pendergrass et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin
Ausra Milano et al.
PLOS ONE (2008)
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis - Application of a latent linear trajectory model
Lynne Shand et al.
ARTHRITIS AND RHEUMATISM (2007)
Share Paper
